Research Programs


NFCR has built science programs that now involve nearly 50 top research laboratories in the U.S. and other countries around the world. NFCR-funded scientists are conducting cutting-edge research around the clock on all major types of cancer and leading the way in many critical research areas.

Click here to view the research achievements accomplished by NFCR scientists in 2013.

Research Discovery Centers

NFCR Center for Metastasis Research
Kansas University Medical Research Institute,  Kansas City, KS
Director: Danny Welch, Ph.D. NFCR Center for Molecular Imaging
Case Western Reserve University, Cleveland, OH
Director: James Basilion, Ph.D.
Joint Tissue Banking Facility
Tianjin Medical University Cancer Institute and Hospital
Director: Haixin Li, M.D., Ph.D. NFCR Center for Targeted Cancer Therapies
Translational Genomic Research Institute (TGEN), Phoenix, AZ
Director: Daniel Von Hoff, M.D.
Co-Director: Laurence Hurley, Ph.D.
NFCR Center for Therapeutic Antibody Engineering
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
Director: Wayne Marasco, M.D., Ph.D. NFCR Center for Cancer Systems Informatics
M.D. Anderson Cancer Center, Houston, TX
Director: Wei Zhang, Ph.D.

NFCR Research Fellows

This program is currently providing long-term and flexible funding to the distinguished and well-established scientists who are leaders in their respective research fields with close connections to research hospitals. This unique funding approach enables NFCR Fellows to perform innovative research in the laboratories and collaborate with clinicians in the hospitals to convert the potential life-saving discoveries into actual applications to benefit cancer patients.

webster_cavenee-bullet Webster Cavenee, Ph.D.
Ludwig Institute for Cancer Research
San Diego, California
waun_ki_hong-bullet Rakesh K. Jain, Ph.D.
Massachusetts General Hospital
Boston, Massachusetts
Yung-Chi Cheng, Ph.D.
Yale University School of Medicine
New Haven, Connecticut
Alan C. Sartorelli, Ph.D.
Yale University
New Haven, Connecticut
curt_civin-bullet Curt I. Civin, M.D.
University of Maryland School of Medicine
Baltimore, Maryland
paul_schimmel-bullet Paul Schimmel, Ph.D.
The Scripps Research Institute
La Jolla, California
harold_dvorak-bullet Harold F. Dvorak, M.D.
Beth Israel Deaconess Medical Center
Boston, Massachusetts
helmut_sies-bullet Helmut Sies, M.D.
Dusseldorf, Germany
Waun Ki Hong, M.D.
MD Anderson Cancer Center
Bronx, New York
W. K. Alfred Yung, Ph.D.
MD Anderson Cancer Center
Houston, Texas
Susan Band Horwitz, Ph.D.
Albert Einstein College of Medicine
Bronx, New York

NFCR Project Directors

This program is designed to encourage outstanding scientists to explore previously uncharted territories in search of the hidden causes of cancer. This research approach cultivates healthy academic competitions and provides scientists a precious opportunity to validate their most innovative ideas.

robert_bast-bullet Robert Bast, Jr., M.D.
MD Anderson Cancer Center
Houston, Texas
rakesh_jain-bullet Kathryn Horwitz, Ph.D.
University of Colorado
Denver, Colorado
esther_chang-bullet Esther H. Chang, Ph.D.
Georgetown University
Washington, DC
Jin Jen, M.D., Ph.D.
Mayo Clinic
Rochester, Minnesota
Laurence J. N. Cooper, M.D., Ph.D.
MD Anderson Cancer Center
Houston, Texas
janos_ladik-bullet Alanna Schepartz, Ph.D.
Yale University Schepartz Laboratory
New Haven, CT
paul_fisher-bullet Paul B. Fisher, M.Ph., Ph.D.
VCU School of Medicine and the Massey Cancer Center
Richmond, Virginia
Alice Shaw, M.D., Ph.D.
Massachusetts General Hospital
Boston, Massachusetts
KateHorwitz_bullet Daniel A. Haber, M.D., Ph.D.
Massachusetts General Hospital Cancer Center
Charleston, Massachusetts
michael_sporn-bullet Michael Sporn, M.D.
Dartmouth Medical School
Hanover, New Hampshire

Success Stories Showcase

SuccessStories09 Cutting off a Tumor's Blood Supply: The Life-Saving Drug AvastinTM SuccessStories03 The Power of Personal Computers to Fight Cancer
SuccessStories10 New Technology that is 14,000 Times Faster than other Technologies SuccessStories20 New Drug for Leukemia, Brain Tumors, and Small Cell Lung Cancer

Click here to view more success stories.